Robotic radiation shielding system reduces radiation-induced DNA damage in operators performing electrophysiological procedures.

Journal: Scientific reports
Published Date:

Abstract

Fluoroscopically guided electrophysiology (EP) procedures expose operators to low doses of ionizing radiation, which can induce DNA double-strand breaks (DSBs) and raises increasing concerns regarding potential health risks. A novel robotic radiation shielding system (RSS) was developed to provide full-body protection by encapsulating the imaging beam and blocking scattered radiation. This study aimed to compare the levels of blood lymphocytes expressing DSB markers, pATM and γ-H2AX, in operators performing EP-procedures with and without RSS. Radiation dose exposure was significantly higher without RSS (p = 0.0278). The level of cells expressing pATM and γ-H2AX was linear correlated with radiation exposure, with neither marker detected at doses below 13.4 µSv. Without RSS, the level of pATM or γ-H2AX positive cells increased significantly immediately after the procedure (8.6-fold, p < 0.0001 and 3.4-fold, p = 0.0279, respectively). After 4 h, marker levels were moderately reduced, and at 24 h, pATM returned to baseline and γ-H2AX decreased to 1.9-fold over baseline (p = 0.9739). In contrast, with RSS, no significant elevation in pATM or γ-H2AX positive cells was observed, suggesting no significant DSB formation. In conclusion, the use of an effective full-body protection system during fluoroscopically guided EP-procedures may help mitigate DSB formation and reduce the genotoxic health risks for operators.

Authors

  • Ziv Sevilya
    Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel. zivse@assuta.co.il.
  • Michael Rahkovich
    Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel.
  • Yonatan Kogan
    Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel.
  • Gergana Marincheva
    Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel.
  • Michal Cipok
    Hematology Laboratory, Assuta Ashdod Medical Center, Ashdod, Israel.
  • Vera Hershkovitz
    Hematology Laboratory, Assuta Ashdod Medical Center, Ashdod, Israel.
  • Erez Barenboim
    Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Eli Israel Lev
    Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel.
  • Avishag Laish-Farkash
    Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel.